Saturday 17 October 2026
Export SPOK’s income statement to Excel — free account
Spok Holdings, Inc.
SPOK Healthcare Health Information Services
Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024. In the quarter to June 2026, revenue fell 1.89%, EPS fell 9.09% and free cash flow fell 2.00%, each against the same quarter a year earlier. Dividend growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
10.61
0.12
−1.12%
Follow SPOK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
17.07 | 17.58 | 17.13 | 21.30 |
+8 more quarters Free account |
P/S ratio |
1.57 | 1.66 | 1.94 | 2.54 | |
P/FCF ratio |
8.42 | 8.87 | 10.76 | 15.70 | |
P/Operating CF |
33.03 | 92.67 | 23.53 | 43.66 | |
P/B ratio |
1.53 | 1.61 | 1.85 | 2.39 | |
Price to Tangible BV |
5.26 | 5.42 | 5.74 | 7.17 | |
EV/Sales |
1.45 | 1.53 | 1.76 | 2.39 | |
EV/EBITDA |
9.97 | 10.63 | 10.62 | 13.96 | |
EV/Operating CF |
6.91 | 7.18 | 8.49 | 12.92 | |
EV/FCF |
7.77 | 8.20 | 9.76 | 14.76 | |
Quick Ratio |
0.87 | 0.85 | 0.98 | 0.96 | |
Current Ratio |
1.09 | 1.09 | 1.18 | 1.21 | |
Net Debt/EBITDA |
(2.61) | (4.97) | (5.27) | (4.10) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.67 | 0.69 | 0.66 | 0.66 | |
Operating CF/Net income |
1.57 | 1.23 | 3.93 | 2.54 | |
Capex/Depreciation |
(0.65) | (0.61) | (1.64) | (0.65) | |
Research and Development Expense of Revenue |
9.37% | 10.40% | 9.05% | 8.84% | |
Selling, General and Administrative Expense of Revenue |
31.78% | 36.48% | 34.12% | 36.73% | |
Intangible Assets out of Total Assets |
0.51 | 0.51 | 0.48 | 0.47 | |
Share Based Compensation of Revenue |
3.95% | 4.43% | 3.74% | 3.69% | |
Graham Net Nets |
(0.02) | (0.03) | (0.01) | 0.00 | |
Graham Number |
9.51 | 9.73 | 11.11 | 11.47 | |
Earnings Yield |
5.86% | 5.69% | 5.84% | 4.70% | |
Free Cash Flow Yield |
11.87% | 11.28% | 9.29% | 6.37% | |
Revenue per Share |
1.68 | 1.60 | 1.65 | 1.64 | |
Operating CF per Share |
0.31 | 0.12 | 0.56 | 0.40 | |
Capex per Share |
(0.03) | (0.03) | (0.07) | (0.03) | |
Free Cash Flow per Share |
0.28 | 0.09 | 0.49 | 0.37 | |
Cash per Share |
0.79 | 0.82 | 1.23 | 1.04 | |
Shareholders Equity per Share |
6.69 | 6.79 | 7.12 | 7.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.69 | 6.79 | 7.12 | 7.22 | |
Free Cash Flow |
5.87 | 1.84 | 10.12 | 7.58 | |
Working Capital |
4.33 | 3.78 | 8.78 | 10.42 | |
Capital Expenditures |
(0.61) | (0.60) | (1.40) | (0.56) | |
Net Current Asset Value |
(5.11) | (5.71) | (1.85) | (1.41) | |
EV/EBIT |
12.21 | 12.97 | 12.47 | 16.36 | |
Capex to Sales |
0.02 | 0.02 | 0.04 | 0.02 | |
Price to Operating Income |
13.24 | 14.03 | 13.76 | 17.40 | |
| Other line items | |||||
Average Receivables |
24.66 | 20.22 | 22.30 | 23.53 | |
Average Payables |
4.15 | 4.11 | 4.80 | 3.64 | |
Average Assets |
202.14 | 199.18 | 211.61 | 213.21 | |
Average Common Equity |
145.40 | 146.35 | 150.56 | 152.49 |
Columns are period end dates